Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Evidence found of a viral epidemic 25000 years back

World Microbiome Day

AI predicts the relation between viruses and mammals

Evidence found of a viral epidemic 25000 years back
  • BiotechToday
  • World

Evidence found of a viral epidemic 25000 years back

bioxone June 27, 2021June 26, 2021

Hari Krishnan R, SRM Institute of Science and Technology

SARS-CoV (2002), MERS-CoV (2006), and ongoing SARS-CoV2 (2019) are a few of the most devastating pandemics in history. All of these were caused by Coronaviruses. A recent study has identified a possible ancient coronavirus epidemic that happened around 20,000 years ago in East Asia regions. This is linked to a selection event that caused the adaptation of virus interacting proteins. These virus-interacting proteins (VIPs) are usually those that play a role in the host defense by interacting with the virus. Using various evolutionary tools, it was predicted that this event happened due to selection pressure in the ancient East Asia populations.

Covid-interacting proteins (CoV-VIPs)

An international study performed by a group of scientists aimed to find out whether coronavirus epidemics in the past have caused adaptation of virus-interacting proteins (VIPs). VIPs have a more functional impact on viruses than any other protein. They analyzed around 420 VIPs that are coronavirus specific from 26 human populations using data from a 1000 genomes project. Out of the 420 VIPs, 332 are SARS-CoV2 interacting proteins identified by mass spectrometry, and the other 88 are from other coronavirus family viruses. 

Evidence of a viral epidemic 25000 years ago

Evolutionary analysis showed evidence of a strong selective sweep signal (the selection that drives fixation of a beneficial mutant in a population) at CoV-VIPs. These were only observed in East Asia populations (China, Korea, Japan, Mongolia, etc.), suggesting that a previous coronavirus-related epidemic prompted an adaptation event in East Asian ancestors. Further, they identified 42 CoV-VIPs that have come under positive selection events from around 25000 years (~900 generations) that exhibit an adaptive response. 50% of these 42 CoV-VIPs were found to have high anti-viral or pro-viral activities, which supported the claim that this selection event likely happened due to a viral epidemic. 

They also infer that these adaptive mutations are found near the regulatory variants in lungs and other tissues infected by COVID-19. British cohorts were used to evaluate the SARS-CoV-2 susceptibility and it was found that the selected 42 VIPs were thought to contribute to the COVID-19 aetiology of the modern British population. This is important because four genes -SMAD3, IMPDH2, PPIB, and GPX1- that are a part of the CoV-VIPs are potential drug targets and there are ongoing clinical trials to investigate their therapeutic efficiency. These four genes are targeted by a set of eleven drugs. Further, five additional CoV-VIPs are targeted by multiple drugs for the treatment of various COVID-19 symptoms. An additional six genes are also called “druggable genomes” and are potential candidates for drug development.

Significance of the study

Exploring ancient viral pandemics can help us understand how different human populations adapt to specific genes that helped them combat viruses. It is also implied that specific human populations with adaptation do not necessarily have a difference in genetic susceptibility to the normal populations. Despite the availability of modern technology in biomedical and healthcare, COVID-19 has emphasized the vulnerability of human populations and studies like these can help us identify and understand viruses that caused pandemics and may cause pandemics in the future. Eventually, these data would help us to identify dangerous viruses and give us a head start for developing vaccines and diagnostics against them.

Also read: Nanodecoys from special lung cells can kill SARS-CoV2

Source:-

  1. Souilmi, Y., Lauterbur, M. E., Tobler, R., Huber, C. D., Johar, A. S., Moradi, S. V., Johnston, W. A., Krogan, N. J., Alexandrov, K., & Enard, D. (2021). An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. Current Biology. Published. https://doi.org/10.1016/j.cub.2021.05.067 
  2. Staff, S. X. (2021, June 24). Genome study reveals East Asian coronavirus epidemic 20,000 years ago. Phys.Org. https://phys.org/news/2021-06-genome-reveals-east-asian-coronavirus.html
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

About the Author- Hari Krishnan is a research enthusiast in Cell biology and Cell signalling. He is currently a final year Biotechnology Engineering student. He is a prolific Scientific writer with vast knowledge in diverse backgrounds of biotechnology. He is constantly focused on improving his knowledge and laboratory skills through various internships. A Chennai native, Hari is a spicy food lover and passionate about music and sports.

Publications-

  1. Krishnan, H. (2021). COMPARISON OF THE DRUG ENTRAPMENT EFFICIENCY OF ALMOND GUM (Badam Pisin) TO SPAN-60 NIOSOMES BY FOLIN- CIOCALTEU ASSAY. BioRxiv. https://doi.org/10.1101/2021.04.03.438312 
  2. Krishnan, H. (2020). TELOMERASE TARGETING IN CANCER. International Research Journal of Modernization in Engineering Technology and Science. https://doi.org/10.3390/cancers12082260   

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged adaptation Ancient East Asia epidemic Evolution Selection Sweep Signal VIP

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

AI predicts the relation between viruses and mammals

BioTech Today June 27, 2021

Agrima Bhatt, Rajasthan University The history of human civilization has shown evidence in the recent past that pandemics are no longer a threat for the future, with much more accessibility to hosts and ease for transfer, pandemics are creating a travesty sooner rather than later. At the end of December 2019 was the onset of […]

Related Post

  • BiotechToday
  • World

A drug to reduce Covid infection by 99%

BioTech Today June 29, 2021June 28, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University All over the world research is currently focused on the development of a drug that might help cure COVID19. At the moment we do not have any treatment for COVID19. Vaccines are the only way the chain of transmission can be broken. Throughout the pandemic, various drugs […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

Rapeseed oil to the rescue of fatty liver diseases

bioxone September 13, 2020September 13, 2020

-Team bioXone Approximate 39% of adult individuals are found to be obese around the world. Obesity is found to be directly linked to NAFLD (Non-Alcoholic Fatty Liver Diseases) which is caused due to an increase in levels of Intrahepatic lipid (IHL) content. A collaborative study was recently conducted in Germany with a sample size of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Novel brain cells named “Gorditas” and “OPC” discovered

BioTech Today June 22, 2021June 22, 2021

Mustafa Vora, DY Patil University Navi Mumbai Scientists have recently discovered two types of novel brain cells that are found to be glial cells. One of them is called a gordita, which is an astrocyte, a type of glial cells. The name ‘gorditas’ comes from the plum-shaped appearance of the squat and round cell bodies. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy